Access Programs
This website is intended for healthcare professionals only.
Our free of charge patient access programs are launched in collaboration with ClinigenDirect. Some programs provide extended access for previous clinical trial patients only. For additional information or medicine request, please contact us or fill out a request form.
Access Programs
| Generic Name | Drug Group | Pack Size | Storage | Approved Indications
| Product Information | |
|---|---|---|---|---|---|---|
| 744 | Brivaracetam 10mg, 25mg, 50mg, 75mg, 100mg | Antiepileptics | 60 tablets | Controlled room temperature | View | |
| 743 | Sotorasib 120mg | Antineoplastic agent (KRAS inhibitor for NSCLC) | 240 tablets | Controlled room temperature | View | |
| 745 | Tislelizumab 100mg/10mL | PD-1 inhibitor | 1 Vial | Cold 2 - 8 C | View |